ask="42.80"
ask_size="100"
average_daily_volume="1117400"
bid="37.80"
bid_size="100"
book_value="4.05"
change="+0.50"
change_from_200_day_moving_average="-6.49"
change_from_50_day_moving_average="-0.74"
change_from_52_week_high="-14.79"
change_From_52_week_low="9.11"
change_in_percent="+1.25%"
close="40.36"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.84"
ex_dividend_date="N/A"
float_shares="85794000"
high="41.46"
high_52_weeks="55.15"
last_trade_date="1/27/2017"
last_trade_price="40.36"
last_trade_size="31583"
last_trade_time="4:00pm"
low="40.31"
low_52_weeks="31.25"
market_capitalization="3.51B"
moving_average_200_day="46.85"
moving_average_50_day="41.10"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="41.30"
pe_ratio="N/A"
peg_ratio="0.67"
percent_change_from_200_day_moving_average="-13.85%"
percent_change_from_50_day_moving_average="-1.79%"
percent_change_from_52_week_high="-26.82%"
percent_change_from_52_week_low="+29.15%"
previous_close="39.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.85"
price_per_sales="230.85"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.55"
stock_exchange="NMS"
symbol="NBIX"
volume="1406754"
weeks_range_52="31.25 - 55.15"
